companies in three key areas
Paragon successfully launched multiple companies and maintains a consistent flow of businesses in development.
- Emalex Biosciences Announces First Patient Dosed in Phase 3 Trial of Ecopipam for Tourette Syndrome March 1, 2023
- Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates February 21, 2023
- Evozyne Creates AI Model with NVIDIA for Novel Protein Design, Expected to Accelerate Drug Development January 12, 2023